![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Biovian announces over €50 million investment in manufacturing facility in Turku, Finland
Biovian, a leading contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, has announced a...
New PAT – Based Strategy Stops Membrane Fouling In SP – TFF
A recent article published in the Journal of Membrane Science presents a new approach for...
Cell And Gene Therapy CDMO Services Market Is On The Rise
The global cell and gene therapy Contract Development and Manufacturing Organization (CDMO) services market, which...
Lack of Experience Hinders CDMOs In Cell And Gene Therapy
CDMOs (contract development and manufacturing organizations) are facing challenges due to the increasing number of...
WHO & Republic of Korea Tie-Up For Biomanufacturing Training
The World Health Organisation as well as the Republic of South Korea have gone ahead...
Cell and Gene Therapy CDMO Targets North American Growth with Major US Acquisition
uBriGene, a cell & gene therapy contract development and manufacturing organization (CDMO), is expanding into...
UNDBIO to Build $100M Insulin Manufacturing Facility in West Virginia
UNDBIO, a South Korean pharmaceutical company focused on diabetic care, will spend $100 million to build...
Lonza’s API Mid-Scale Manufacturing Facility Expansion in Nansha Enters Commercial Operation
Lonza announces the start of new mid-scale manufacturing assets at its API manufacturing center in...
How ‘First-Time Right’ Formulations Can Help Address the Challenge of Affordable Medicines
For years, global healthcare systems have been facing the triple threat of rising incidences of...
By 2030, OSD Contract Manufacturing Will Be $54.7 Billion
The global oral solid dosage (OSD) contract manufacturing market is anticipated to reach $54.7 billion...